{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:30:58Z","timestamp":1790253058385,"version":"4.1.0"},"reference-count":110,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Mitochondrial disorders are an increasingly recognized cause of heart dysfunction, with the primary manifestations being cardiomyopathy and conduction defects. This review focuses on the complex genetics of mitochondrial disease and recently discovered conditions that affect mitochondrial function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Next-generation sequencing techniques, especially whole-exome sequencing, have led to the discovery of a number of conditions that cause mitochondrial dysfunction and subsequent cardiac abnormalities. Nuclear DNA defects are the main cause of mitochondrial disease in children, with disease pathogenesis being related to either abnormalities in specific mitochondrial electron transport chain subunits or in proteins related to subunit or mitochondrial DNA maintenance, mitochondrial protein translation, lipid bilayer structure, or other aspects of mitochondrial function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Currently, symptomatic therapy using standard medications targeting relief of complications is the primary approach to treatment. There are no US Food and Drug Administration-approved therapies for the specific treatment of mitochondrial disease. However, on the basis of recent advances in understanding of the pathophysiology of these complex disorders, various novel approaches are either in clinical trials or in development.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000535","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T17:49:16Z","timestamp":1500400156000},"page":"541-551","source":"Crossref","is-referenced-by-count":19,"title":["Pediatric mitochondrial diseases and the heart"],"prefix":"10.1097","volume":"29","author":[{"given":"Gregory M.","family":"Enns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.cjca.2015.08.017","article-title":"Mitochondrial diseases and cardiomyopathies","volume":"31","author":"Brunel-Guitton","year":"2015","journal-title":"Can J Cardiol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fcvm.2016.00025","article-title":"Mitochondrial cardiomyopathies","volume":"3","author":"El-Hattab","year":"2016","journal-title":"Front Cardiovasc Med"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/heartjnl-2015-308193","article-title":"Mitochondrial disease and the heart","volume":"103","author":"Limongelli","year":"2017","journal-title":"Heart"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.mito.2010.02.003","article-title":"Left ventricular noncompaction is associated with mutations in the mitochondrial genome","volume":"10","author":"Tang","year":"2010","journal-title":"Mitochondrion"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/clc.20224","article-title":"Histiocytoid cardiomyopathy: a mitochondrial disorder","volume":"31","author":"Finsterer","year":"2008","journal-title":"Clin Cardiol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ymgme.2011.02.007","article-title":"Dilation of the aortic root in mitochondrial disease patients","volume":"103","author":"Brunetti-Pierri","year":"2011","journal-title":"Mol Genet Metab"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.braindev.2012.02.011","article-title":"Pulmonary hypertension in a child with mitochondrial A3243G point mutation","volume":"34","author":"Hung","year":"2012","journal-title":"Brain Dev"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ijcard.2014.11.014","article-title":"Cardiac manifestations of primary mitochondrial disorders","volume":"177","author":"Finsterer","year":"2014","journal-title":"Int J Cardiol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/eurheartj\/ehs275","article-title":"Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management","volume":"33","author":"Bates","year":"2012","journal-title":"Eur Heart J"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13311-012-0167-0","article-title":"Mitochondrial disease in childhood: mtDNA encoded","volume":"10","author":"Saneto","year":"2013","journal-title":"Neurotherapeutics"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s13311-013-0185-6","article-title":"Mitochondrial disease in childhood: nuclear encoded","volume":"10","author":"Goldstein","year":"2013","journal-title":"Neurotherapeutics"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bbabio.2016.02.012","article-title":"Mitochondrial complex I-linked disease","volume":"1857","author":"Rodenburg","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jmedgenet-2012-101159","article-title":"Complex I deficiency: clinical features, biochemistry and molecular genetics","volume":"49","author":"Fassone","year":"2012","journal-title":"J Med Genet"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1038\/sj.emboj.7601748","article-title":"Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease","volume":"26","author":"Dunning","year":"2007","journal-title":"EMBO J"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10545-012-9492-z","article-title":"Natural disease course and genotype-phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases","volume":"35","author":"Koene","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.706","article-title":"Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency","volume":"42","author":"Haack","year":"2010","journal-title":"Nat Genet"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/brain\/awq273","article-title":"Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene","volume":"134","author":"Gerards","year":"2011","journal-title":"Brain"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajmg.a.35714","article-title":"Complex II deficiency \u2013 a case report and review of the literature","volume":"161A","author":"Jain-Ghai","year":"2013","journal-title":"Am J Med Genet A"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10545-012-9536-4","article-title":"Clinical and biochemical features associated with BCS1L mutation","volume":"36","author":"Al-Owain","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5414\/NPP28143","article-title":"A novel homozygous SCO2 mutation, p.G193S, causing fatal infantile cardioencephalomyopathy","volume":"28","author":"Mobley","year":"2009","journal-title":"Clin Neuropathol"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ajhg.2011.03.002","article-title":"A mutation in C2orf64 causes impaired cytochrome c oxidase assembly and mitochondrial cardiomyopathy","volume":"88","author":"Huigsloot","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajhg.2011.11.027","article-title":"Mutations in C12orf62, a factor that couples COX I synthesis with cytochrome c oxidase assembly, cause fatal neonatal lactic acidosis","volume":"90","author":"Weraarpachai","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000000716","article-title":"Mitochondrial EFTs defects in juvenile-onset Leigh disease, ataxia, neuropathy, and optic atrophy","volume":"83","author":"Ahola","year":"2014","journal-title":"Neurology"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jmg.2007.053116","article-title":"Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation","volume":"44","author":"Saada","year":"2007","journal-title":"J Med Genet"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/humu.21562","article-title":"Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy","volume":"32","author":"Galmiche","year":"2011","journal-title":"Hum Mutat"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/jmedgenet-2012-101375","article-title":"Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to underlie mitochondrial infantile cardiomyopathy","volume":"50","author":"Carroll","year":"2013","journal-title":"J Med Genet"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajhg.2010.06.001","article-title":"Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia \u2013 MLASA syndrome","volume":"87","author":"Riley","year":"2010","journal-title":"Am J Hum Genet"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ajhg.2011.04.006","article-title":"Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy","volume":"88","author":"Gotz","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajhg.2013.06.006","article-title":"ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy","volume":"93","author":"Haack","year":"2013","journal-title":"Am J Hum Genet"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ajhg.2014.10.017","article-title":"Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy","volume":"95","author":"Kopajtich","year":"2014","journal-title":"Am J Hum Genet"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ajhg.2012.04.011","article-title":"Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis","volume":"90","author":"Ghezzi","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/humu.22393","article-title":"MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast","volume":"34","author":"Baruffini","year":"2013","journal-title":"Hum Mutat"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/hmg\/ddu743","article-title":"MTO1 mediates tissue specificity of OXPHOS defects via tRNA modification and translation optimization, which can be bypassed by dietary intervention","volume":"24","author":"Tischner","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajhg.2015.06.011","article-title":"TRMT5 mutations cause a defect in posttranscriptional modification of mitochondrial tRNA associated with multiple respiratory-chain deficiencies","volume":"97","author":"Powell","year":"2015","journal-title":"Am J Hum Genet"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s13311-013-0177-6","article-title":"Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options","volume":"10","author":"El-Hattab","year":"2013","journal-title":"Neurotherapeutics"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ajhg.2013.07.017","article-title":"Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance","volume":"93","author":"Bonnen","year":"2013","journal-title":"Am J Hum Genet"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jmedgenet-2015-103361","article-title":"Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation","volume":"53","author":"Spiegel","year":"2016","journal-title":"J Med Genet"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajhg.2014.12.023","article-title":"COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency","volume":"96","author":"Brea-Calvo","year":"2015","journal-title":"Am J Hum Genet"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10545-014-9749-9","article-title":"Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency","volume":"38","author":"Desbats","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/hmg\/ddw046","article-title":"Defining functional classes of Barth syndrome mutation in humans","volume":"25","author":"Lu","year":"2016","journal-title":"Hum Mol Genet"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11745-016-4229-7","article-title":"Barth syndrome: connecting cardiolipin to cardiomyopathy","volume":"52","author":"Ikon","year":"2017","journal-title":"Lipids"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ymgme.2014.03.007","article-title":"Clinical laboratory studies in Barth Syndrome","volume":"112","author":"Vernon","year":"2014","journal-title":"Mol Genet Metab"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ajmg.c.31372","article-title":"Barth syndrome","volume":"163C","author":"Jefferies","year":"2013","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15252\/emmm.201505644","article-title":"Cardiac-specific succinate dehydrogenase deficiency in Barth syndrome","volume":"8","author":"Dudek","year":"2016","journal-title":"EMBO Mol Med"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jmg.2005.036657","article-title":"Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition","volume":"43","author":"Davey","year":"2006","journal-title":"J Med Genet"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/pr.2012.92","article-title":"New mutation of mitochondrial DNAJC19 causing dilated and noncompaction cardiomyopathy, anemia, ataxia, and male genital anomalies","volume":"72","author":"Ojala","year":"2012","journal-title":"Pediatr Res"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ng.246","article-title":"TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy","volume":"40","author":"Cizkova","year":"2008","journal-title":"Nat Genet"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ajhg.2011.12.005","article-title":"Lack of the mitochondrial protein acylglycerol kinase causes Sengers syndrome","volume":"90","author":"Mayr","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10545-016-9977-2","article-title":"Pathogenic variants in HTRA2 cause an early-onset mitochondrial syndrome associated with 3-methylglutaconic aciduria","volume":"40","author":"Olahova","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"R51-20230918","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ajhg.2015.12.009","article-title":"Bi-allelic truncating mutations in TANGO2 cause infancy-onset recurrent metabolic crises with encephalocardiomyopathy","volume":"98","author":"Kremer","year":"2016","journal-title":"Am J Hum Genet"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ajhg.2016.06.027","article-title":"Sudden cardiac death due to deficiency of the mitochondrial inorganic pyrophosphatase PPA2","volume":"99","author":"Kennedy","year":"2016","journal-title":"Am J Hum Genet"},{"key":"R53-20230918","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13073-016-0360-6","article-title":"MIPEP recessive variants cause a syndrome of left ventricular noncompaction, hypotonia, and infantile death","volume":"8","author":"Eldomery","year":"2016","journal-title":"Genome Med"},{"key":"R54-20230918","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2014.12.038","article-title":"Systematic review of cardiac electrical disease in Kearns\u2013Sayre syndrome and mitochondrial cytopathy","volume":"181","author":"Kabunga","year":"2015","journal-title":"Int J Cardiol"},{"key":"R55-20230918","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1054\/jcaf.2000.19232","article-title":"The complete sequence of mtDNA genes in idiopathic dilated cardiomyopathy shows novel missense and tRNA mutations","volume":"6","author":"Marin-Garcia","year":"2000","journal-title":"J Card Fail"},{"key":"R56-20230918","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.humpath.2012.10.011","article-title":"Cardiomyopathies due to homoplasmic mitochondrial tRNA mutations: morphologic and molecular features","volume":"44","author":"Giordano","year":"2013","journal-title":"Hum Pathol"},{"key":"R57-20230918","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1203\/00006450-200009000-00008","article-title":"A missense mutation in the mitochondrial cytochrome b gene in a revisited case with histiocytoid cardiomyopathy","volume":"48","author":"Andreu","year":"2000","journal-title":"Pediatr Res"},{"key":"R58-20230918","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/mgg3.5","article-title":"MT-CYB mutations in hypertrophic cardiomyopathy","volume":"1","author":"Hagen","year":"2013","journal-title":"Mol Genet Genomic Med"},{"key":"R59-20230918","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ejhg.2014.85","article-title":"Mitochondrial complex IV deficiency, caused by mutated COX6B1, is associated with encephalomyopathy, hydrocephalus and cardiomyopathy","volume":"23","author":"Abdulhag","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"R60-20230918","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jmg.2008.063149","article-title":"Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes","volume":"46","author":"Ware","year":"2009","journal-title":"J Med Genet"},{"key":"R61-20230918","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijcard.2016.01.026","article-title":"Rapidly progressive infantile cardiomyopathy with mitochondrial respiratory chain complex V deficiency due to loss of ATPase 6 and 8 protein","volume":"207","author":"Imai","year":"2016","journal-title":"Int J Cardiol"},{"key":"R62-20230918","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejmg.2012.06.002","article-title":"Mitochondrial DNA m.3242G>A mutation, an under diagnosed cause of hypertrophic cardiomyopathy and renal tubular dysfunction?","volume":"55","author":"Wortmann","year":"2012","journal-title":"Eur J Med Genet"},{"key":"R63-20230918","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bbrc.2015.01.157","article-title":"Early onset cardiomyopathy associated with the mitochondrial tRNALeu((UUR)) 3271T>C MELAS mutation","volume":"458","author":"Brisca","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"R64-20230918","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.0b013e3181d0ccf4","article-title":"Cardiac involvement is frequent in patients with the m.8344A>G mutation of mitochondrial DNA","volume":"74","author":"Wahbi","year":"2010","journal-title":"Neurology"},{"issue":"(suppl 1)","key":"R65-20230918","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jnc.12217","article-title":"Cardiomyopathy of Friedreich ataxia","volume":"126","author":"Weidemann","year":"2013","journal-title":"J Neurochem"},{"issue":"(suppl 1)","key":"R66-20230918","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jnc.12303","article-title":"Mitochondrial pathophysiology in Friedreich's ataxia","volume":"126","author":"Gonzalez-Cabo","year":"2013","journal-title":"J Neurochem"},{"key":"R67-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2016.06.007","article-title":"Disturbance of mitochondrial functions provoked by the major long-chain 3-hydroxylated fatty acids accumulating in MTP and LCHAD deficiencies in skeletal muscle","volume":"36","author":"Cecatto","year":"2016","journal-title":"Toxicol In Vitro"},{"key":"R68-20230918","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2015.09.004","article-title":"Disorders of carnitine biosynthesis and transport","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol Genet Metab"},{"key":"R69-20230918","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","article-title":"The biochemistry and physiology of mitochondrial fatty acid beta-oxidation and its genetic disorders","volume":"78","author":"Houten","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"R70-20230918","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10545-012-9542-6","article-title":"Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients","volume":"36","author":"Baruteau","year":"2013","journal-title":"J Inherit Metab Dis"},{"issue":"(suppl 3)","key":"R71-20230918","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000448321","article-title":"Primary carnitine deficiency and newborn screening for disorders of the carnitine cycle","volume":"68","author":"Longo","year":"2016","journal-title":"Ann Nutr Metab"},{"key":"R72-20230918","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10545-015-9839-3","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: The initial presentation","volume":"38","author":"Kolker","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"R73-20230918","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10545-015-9840-x","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: The evolving clinical phenotype","volume":"38","author":"Kolker","year":"2015","journal-title":"J Inherit Metab Dis"},{"issue":"(suppl 1)","key":"R74-20230918","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1007\/s10545-009-1084-1","article-title":"Unusual presentation of propionic acidaemia as isolated cardiomyopathy","volume":"32","author":"Lee","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"R75-20230918","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00431-014-2359-6","article-title":"Propionic acidemia in a previously healthy adolescent with acute onset of dilated cardiomyopathy","volume":"173","author":"Laemmle","year":"2014","journal-title":"Eur J Pediatr"},{"key":"R76-20230918","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1096\/fj.08-121848","article-title":"Mitochondrial dysfunction in mut methylmalonic acidemia","volume":"23","author":"Chandler","year":"2009","journal-title":"FASEB J"},{"key":"R77-20230918","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1203\/PDR.0b013e3181a7c270","article-title":"Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria","volume":"66","author":"de Keyzer","year":"2009","journal-title":"Pediatr Res"},{"key":"R78-20230918","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/BJ20060221","article-title":"Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins","volume":"398","author":"Schwab","year":"2006","journal-title":"Biochem J"},{"key":"R79-20230918","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ymgme.2005.04.004","article-title":"Clinical, pathological, and biochemical studies in a patient with propionic acidemia and fatal cardiomyopathy","volume":"85","author":"Mardach","year":"2005","journal-title":"Mol Genet Metab"},{"key":"R80-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2014.12.005","article-title":"Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript processing","volume":"21","author":"Chatfield","year":"2015","journal-title":"Mitochondrion"},{"key":"R81-20230918","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2007.11.018","article-title":"The in-depth evaluation of suspected mitochondrial disease","volume":"94","author":"Haas","year":"2008","journal-title":"Mol Genet Metab"},{"key":"R82-20230918","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mito.2013.07.116","article-title":"Practice patterns of mitochondrial disease physicians in North America. Part 1: Diagnostic and clinical challenges","volume":"14","author":"Parikh","year":"2014","journal-title":"Mitochondrion"},{"key":"R83-20230918","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.mito.2013.09.003","article-title":"Practice patterns of mitochondrial disease physicians in North America. Part 2: Treatment, care and management","volume":"13","author":"Parikh","year":"2013","journal-title":"Mitochondrion"},{"key":"R84-20230918","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"17","author":"Parikh","year":"2015","journal-title":"Genet Med"},{"key":"R85-20230918","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.mito.2013.02.001","article-title":"Next generation molecular diagnosis of mitochondrial disorders","volume":"13","author":"Wong","year":"2013","journal-title":"Mitochondrion"},{"key":"R86-20230918","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.bbabio.2016.02.022","article-title":"New genes and pathomechanisms in mitochondrial disorders unraveled by NGS technologies","volume":"1857","author":"Legati","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"R87-20230918","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.bbagen.2014.01.025","article-title":"Diagnosis and molecular basis of mitochondrial respiratory chain disorders: exome sequencing for disease gene identification","volume":"1840","author":"Ohtake","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"R88-20230918","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2014.7184","article-title":"Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies","volume":"312","author":"Taylor","year":"2014","journal-title":"JAMA"},{"key":"R89-20230918","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-015-9823-y","article-title":"Whole exome sequencing of suspected mitochondrial patients in clinical practice","volume":"38","author":"Wortmann","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"R90-20230918","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00392-011-0387-z","article-title":"Cardiovascular magnetic resonance imaging (CMR) reveals characteristic pattern of myocardial damage in patients with mitochondrial myopathy","volume":"101","author":"Yilmaz","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"R91-20230918","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12968-015-0145-x","article-title":"Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy","volume":"17","author":"Florian","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"key":"R92-20230918","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ajhg.2016.04.006","article-title":"Riboflavin-responsive and -nonresponsive mutations in FAD synthase cause multiple acyl-CoA dehydrogenase and combined respiratory-chain deficiency","volume":"98","author":"Olsen","year":"2016","journal-title":"Am J Hum Genet"},{"key":"R93-20230918","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13023-014-0217-2","article-title":"Follow-up of folinic acid supplementation for patients with cerebral folate deficiency and Kearns\u2013Sayre syndrome","volume":"9","author":"Quijada-Fraile","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"R94-20230918","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1046\/j.1365-2141.2001.02774.x","article-title":"A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome","volume":"113","author":"Gritli","year":"2001","journal-title":"Br J Haematol"},{"key":"R95-20230918","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/pan.12158","article-title":"Anesthetic considerations in patients with mitochondrial defects","volume":"23","author":"Niezgoda","year":"2013","journal-title":"Paediatr Anaesth"},{"key":"R96-20230918","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2344\/anpr-63-03-08","article-title":"Anesthetic management of a child with unspecified mitochondrial disease in an outpatient dental setting","volume":"64","author":"Gordon","year":"2017","journal-title":"Anesth Prog"},{"key":"R97-20230918","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrneurol.2013.129","article-title":"New treatments for mitochondrial disease-no time to drop our standards","volume":"9","author":"Pfeffer","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R98-20230918","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13311-013-0176-7","article-title":"Review of clinical trials for mitochondrial disorders: 1997\u20132012","volume":"10","author":"Kerr","year":"2013","journal-title":"Neurotherapeutics"},{"key":"R99-20230918","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.3390\/jcm6050050","article-title":"Glutathione as a redox biomarker in mitochondrial disease-implications for therapy","volume":"6","author":"Enns","year":"2017","journal-title":"J Clin Med"},{"key":"R100-20230918","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1042\/BST20160085","article-title":"Toward a therapy for mitochondrial disease","volume":"44","author":"Viscomi","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"R101-20230918","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-017-0605-5","article-title":"The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome","volume":"12","author":"Huang","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"R102-20230918","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1194\/jlr.M072033","article-title":"Triheptanoin: long-term effects in the very long-chain acyl-CoA dehydrogenase-deficient mouse","volume":"58","author":"Tucci","year":"2017","journal-title":"J Lipid Res"},{"key":"R103-20230918","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ymgme.2017.02.005","article-title":"UX007 for the treatment of long chain-fatty acid oxidation disorders: safety and efficacy in children and adults following 24 weeks of treatment","volume":"120","author":"Vockley","year":"2017","journal-title":"Mol Genet Metab"},{"key":"R104-20230918","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2015.06.006","article-title":"Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment \u2013 a retrospective chart review","volume":"116","author":"Vockley","year":"2015","journal-title":"Mol Genet Metab"},{"key":"R105-20230918","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ymgme.2016.08.008","article-title":"Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders","volume":"119","author":"Vockley","year":"2016","journal-title":"Mol Genet Metab"},{"key":"R106-20230918","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/heart.86.5.570","article-title":"Heart transplantation in children with mitochondrial cardiomyopathy","volume":"86","author":"Bonnet","year":"2001","journal-title":"Heart"},{"key":"R107-20230918","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1399-3046.2007.00719.x","article-title":"Cardiac transplantation in a 14-yr-old patient with mitochondrial encephalomyopathy","volume":"11","author":"Schmauss","year":"2007","journal-title":"Pediatr Transplant"},{"key":"R108-20230918","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijcard.2011.11.063","article-title":"Mitochondrial respiratory chain disease in children undergoing cardiac transplantation: a prospective study","volume":"155","author":"Bates","year":"2012","journal-title":"Int J Cardiol"},{"key":"R109-20230918","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome","volume":"8","author":"Clarke","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R110-20230918","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymgme.2016.04.009","article-title":"Solid organ transplantation in primary mitochondrial disease: proceed with caution","volume":"118","author":"Parikh","year":"2016","journal-title":"Mol Genet Metab"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008480-201710000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:06:08Z","timestamp":1695002768000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201710000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000535","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}